Prospective, multivariate evaluation of CLOtest performance

Area of Science:

• Gastroenterology
• Infectious Diseases
• Diagnostic Microbiology

Background:

• The CLOtest is a rapid diagnostic method for detecting Helicobacter pylori (H. pylori) infection.
• Accurate H. pylori diagnosis is crucial for effective treatment and management of related gastrointestinal conditions.
• Factors influencing CLOtest performance require further investigation to enhance diagnostic yield.

Purpose of the Study:

• To prospectively evaluate the impact of various factors on the performance of the CLOtest for H. pylori detection.
• Key factors examined include medication use (aspirin, NSAIDs, H2-blockers, PPIs), alcohol intake, race, age, prior H. pylori eradication history, and gastric biopsy site.

Main Methods:

• Prospective study involving 117 patients, with 50 confirmed H. pylori infections.
• Gastric biopsy specimens were collected from the antrum, greater curve, and proximal stomach.
• H. pylori status was definitively determined using Giemsa staining, with CLOtest performance compared against histopathology results from different biopsy sites.

Main Results:

• CLOtest sensitivity and specificity varied based on biopsy site; combining antrum and body samples improved sensitivity to 82.0%.
• Absence of alcohol consumption was significantly associated with CLOtest concordance (p < 0.02).
• No history of H. pylori eradication attempts (p = 0.04) and African-American race (p < 0.03) were also independently associated with CLOtest accuracy in specific sites.

Conclusions:

• Collecting gastric biopsy specimens from both the antrum and body enhances CLOtest sensitivity for H. pylori detection.
• CLOtest performance is demonstrably influenced by demographic and clinical factors, including alcohol consumption, race, and eradication history.